Αποτελέσματα Αναζήτησης
13 Μαρ 2024 · The 2022 MASCC guideline on cannabinoids for GI symptoms in adults with cancer suggests against use of cannabinoids in the following circumstances: treatment of nausea and vomiting unrelated to chemotherapy; first-line treatment in the prevention of CINV; and prevention of radiotherapy-induced nausea and vomiting. 40 The MASCC guideline ...
Chemotherapy, the primary choice for treatment of cancer, is often ineffective or/and presents itself with many debilitating side effects, including loss of appetite, nausea, insomnia, and anxiety. Components of cannabis extracts, including cannabinoids and terpenes, may present an alternative for controlling side effects and may be used for ...
11 Μαρ 2022 · Research in recent years has yielded several compounds that exert promising effects on tumour cells and tissues in addition to the psychoactive Δ 9 -tetrahydrocannabinol, such as the...
13 Μαρ 2024 · In 2024, ASCO published a guideline on the use of cannabis and cannabinoids by adults with cancer. 1 The guideline provides strategies for open, nonjudgmental communication and also discusses evidence regarding cannabis and cannabinoids as cancer-directed therapy and for managing cancer symptoms and treatment side effects.
Cannabinoids, including Δ9-THC, CBD, and CBG, exhibit significant anticancer activities such as apoptosis induction, autophagy stimulation, cell cycle arrest, anti-proliferation, anti-angiogenesis, and metastasis inhibition. Clinical trials have demonstrated cannabinoids’ efficacy in tumor regression and health improvement in palliative care.
5 ημέρες πριν · This study investigates the patterns of cannabis use among a socio-demographically diverse group of cancer patients undergoing active treatment at an NCI-designated cancer center, focusing on sources, dominant cannabinoids, frequency, and reasons for use, whether for symptom management, coping with treatment side effects, or other health ...
24 Ιουν 2022 · Several studies support the efficacy of cannabis for various cancer and treatment-related symptoms, such as chemotherapy-induced nausea and cancer pain. Although formulations and dosing guidelines for clinicians do not formally exist at present, attention to tetrahydrocannabinol concentration and understanding of risks with inhalation can ...
